US Aid Cuts Put Ghana’s Child Immunisation Progress Under Pressure

Funding shock hits a system built on fragile gains

Ghana’s child immunisation programme is under renewed pressure after cuts to United States aid widened an already difficult financing environment for health services. Reporting from Accra this week described a projected health shortfall of about $78.2 million within a broader funding gap affecting multiple programmes, including malaria prevention, maternal and child health, nutrition, family planning and HIV services. The immediate concern is not only whether vaccines will be available, but whether the systems that deliver them — transport, cold chain, supervision and community follow-up — can keep functioning at the level needed to sustain coverage. ([aljazeera.com](https://www.aljazeera.com/news/2026/8/28/us-aid-cuts-threaten-ghanas-child-immunisation-gains?utm_source=openai))

The timing matters because Ghana has spent years building up routine immunisation and adding newer vaccines to its schedule. WHO and UNICEF materials published in recent years show that the country has been working through a transition toward greater self-financing, while still relying on external support for key parts of the programme. UNICEF said in 2024 that Ghana’s timely vaccine financing was helping preserve regular supply, but it also warned that development aid was declining and domestic financing still needed strengthening. ([unicef.org](https://www.unicef.org/ghana/press-releases/unicef-commends-ghana-strengthening-immunisation-programme-through-timely-vaccine?utm_source=openai))

What the aid cuts could affect

The largest risk is not necessarily the headline vaccine doses themselves, but the infrastructure that keeps immunisation routine and predictable. WHO says its support to Ghana’s Expanded Programme on Immunisation includes micro-planning, training, data management, cold chain and logistics, vaccine management, injection safety, monitoring and social mobilisation. If budgets tighten, those are exactly the areas that can be reduced first, even though they are central to making sure children receive doses on time and finish the full schedule. ([afro.who.int](https://www.afro.who.int/countries/ghana/topic/health-topics-ghana?utm_source=openai))

Al Jazeera’s report cited a study in northern Ghana finding that 75% of districts surveyed experienced vaccine delays or irregular supplies when donor support was withdrawn, with problems affecting cold-chain equipment, delivery kits and transport fuel. That kind of disruption can quickly translate into missed appointments, longer travel for families and lower completion rates for multi-dose vaccines. In practical terms, a health budget problem becomes a community access problem. ([aljazeera.com](https://www.aljazeera.com/news/2026/8/28/us-aid-cuts-threaten-ghanas-child-immunisation-gains?utm_source=openai))

The challenge is especially serious for rural districts and poorer households, where a missed outreach session can mean months before another chance comes along. If fuel, cold boxes, outreach allowances or data systems are constrained, health workers may be forced to prioritise fewer locations, which leaves zero-dose children and children in missed communities at greater risk. That is consistent with the direction of global immunisation policy, which now explicitly prioritises missed communities and sustainability, but policy alone cannot replace operational funding on the ground. ([gavi.org](https://www.gavi.org/our-work/strategy/phase-6-2026-2030?utm_source=openai))

Ghana has made progress, but sustaining it costs more than introducing a vaccine

Ghana is not starting from zero. The country was among the first in Africa to introduce the RTS,S malaria vaccine into routine immunisation, and Reuters reported earlier in 2026 that malaria infections had fallen from about 6.7 million in 2018 to 5.3 million in 2024, with two new vaccines helping reduce child deaths further. That progress shows the value of immunisation when coverage is strong and delivery systems work. It also shows why funding setbacks are worrying: gains against malaria and other vaccine-preventable illnesses can be weakened if the delivery network frays. ([investing.com](https://www.investing.com/news/stock-market-news/new-malaria-vaccines-helped-ghana-slash-child-deaths-then-trump-others-cut-aid-4471952?utm_source=openai))

UNICEF and WHO have both framed Ghana’s task as one of sustainable financing. UNICEF’s 2025 health budget brief said the government met its 2025 vaccine co-financing commitment of $24.5 million, which it described as helping safeguard routine immunisation and prevent stockouts. But the same brief projected a widening vaccine-financing gap over the coming years, partly because of the eventual withdrawal of Gavi support and the introduction of newer vaccines such as HPV and hepatitis B. That means the country faces a dual task: maintaining today’s coverage while preparing to pay more of the bill itself in the years ahead. ([unicef.org](https://www.unicef.org/ghana/media/8681/file/Health%20Budget%20Brief%202025.pdf.pdf?utm_source=openai))

Gavi’s current co-financing framework makes clear that countries receiving support must contribute a share of vaccine costs, and the organisation’s 2026–2030 strategy says sustainability, country ownership and support for zero-dose communities are central to its next phase. In Ghana’s case, the policy direction is clear, but the pace of transition can still create real strain if domestic budgets and donor support do not align. ([gavi.org](https://www.gavi.org/partner-countries/programmatic-policies/co-financing-policy?utm_source=openai))

Government and partners push for domestic solutions

Ghanaian health officials and partners have already been warning that immunisation needs stronger domestic financing. In February 2026, UNICEF and partners backed the launch of a parliamentary caucus on immunisation, arguing that legislators would need to play a bigger role in oversight and budget protection as the country moves toward self-financing. WHO’s Africa office said the caucus was intended to strengthen predictable funding and political commitment for vaccine-preventable disease prevention. ([afro.who.int](https://www.afro.who.int/photo-story/parliamentary-caucus-immunization-launched-strengthen-sustainable-vaccine-financing?utm_source=openai))

That push has become more urgent after the US aid cuts. A report from Ghana’s national news agency in June said experts were urging sustainable financing for primary healthcare, noting that the country’s immunisation plans require substantial funding and that domestic resource mobilisation must improve. The argument is straightforward: if external funding becomes less reliable, Ghana will need to rely more heavily on its own fiscal choices, including budget prioritisation, health insurance mechanisms and better execution of committed funds. ([gna.org.gh](https://gna.org.gh/2026/06/sustainable-financing-key-to-safeguarding-ghanas-primary-healthcare-gains-experts/?utm_source=openai))

There is also a governance dimension. Reuters reported earlier in 2026 that Ghana had walked away from a proposed US health agreement over sensitive data concerns, showing that the bilateral health relationship has already been under strain this year. Against that background, the latest aid cuts do not appear as an isolated event, but as part of a broader reset in how Ghana and its partners will finance health programmes going forward. ([citinewsroom.com](https://www.citinewsroom.com/2026/04/ghana-walks-away-from-us-health-agreement-over-sensitive-data-concerns/?utm_source=openai))

Why the stakes go beyond vaccines

If routine immunisation weakens, the cost is not just lower vaccination coverage. Missed doses can increase the risk of outbreaks, raise treatment costs for families and put more pressure on clinics already dealing with malaria, maternal health needs and child nutrition problems. Ghana’s own reporting in recent years has repeatedly tied health outcomes to the strength of primary care financing, and UNICEF has warned that fiscal constraints can ripple across essential child services. ([unicef.org](https://www.unicef.org/ghana/reports/sustainable-financing-health-and-nutrition?utm_source=openai))

The bigger lesson from Ghana is that immunisation success is cumulative. A vaccine introduction can deliver quick gains, but keeping those gains requires long-term spending on staff, fuel, cold chain, record-keeping, outreach and community trust. Aid cuts expose how dependent even relatively advanced programmes can be on a mix of external grants and domestic commitments. Ghana now has to decide whether the latest funding shock becomes a temporary setback or the moment it accelerates a more durable financing model. ([gavi.org](https://www.gavi.org/programmes-impact/programmatic-policies/eligibility-co-financing-policies?utm_source=openai))

Bottom line

Ghana’s immunisation achievements are real, but they are not self-sustaining by default. The current US aid cuts have widened financing gaps at a moment when the country is already preparing for greater vaccine self-financing, making the next few budget cycles critical for child health outcomes. Whether coverage holds will depend less on vaccine science than on whether Ghana can keep the machinery of routine delivery working at scale. ([aljazeera.com](https://www.aljazeera.com/news/2026/8/28/us-aid-cuts-threaten-ghanas-child-immunisation-gains?utm_source=openai))

Sources:

• Al Jazeera
• UNICEF Ghana
• UNICEF Ghana
• WHO Africa
• Gavi
• Reuters via Investing.com